Hrt Financial LP Eye Point Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$5.71 - $24.13 $86,923 - $367,330	-15,223 Reduced 63.01%	8,935 $206,000
Q3 2023 Nov 13, 2023	BUY	$7.99 - $15.36 $193,022 - $371,066	24,158 New	24,158 $193,000
Q2 2021 Aug 16, 2021	SELL	$8.69 - $11.08 $211,158 - $269,232	-24,299 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.89 - $14.92 $216,018 - $362,541	24,299 New	24,299 $246,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.